Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Whitehawk Therapeutics to Participate in Jones Trading Post-AACR Fireside Chat Series
Friday, April 17, 2026Whitehawk Therapeutics Inc Nasdaq WHWK a clinicalstage oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved antibody drug conjugate ADC
Takara Bio USA, Inc. Launches Certified Service Provider Program to Advance Research Using NGS and Single-Cell Technologies
Friday, April 17, 2026Takara Bio USA Inc Takara Bio USA a wholly owned subsidiary of Takara Bio Inc Takara Bio today announced the launch of the Takara Bio Certified Service Provider CSP Program which equips service providers
Arbutus Receives U.S. FDA Fast Track Designation for Imdusiran for the Treatment of Chronic Hepatitis B
Thursday, April 16, 2026Arbutus Biopharma Corporation Nasdaq ABUS Arbutus or the Company a clinicalstage biopharmaceutical company focused on infectious disease today announced that the US Food and Drug Administration FDA
BostonGene and ImmunoGenesis Announce Strategic Partnership to Overcome Immunotherapy Resistance
Wednesday, April 15, 2026BostonGene developer of the leading AI foundation model for tumor and immune biology and ImmunoGenesis a clinicalstage biotech company developing innovative sciencedriven immunotherapies
Kincell Bio Announces Strategic Expansion of Research Triangle Park Facility to Support Late-Stage and Commercial Cell Therapy Manufacturing Programs
Wednesday, April 15, 2026Kincell Bio a leading contract development and manufacturing organization CDMO supporting autologous and allogeneic cell therapy programs today announced a significant strategic investment to expand and strengthen its Research Triangle
4D Path Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Predictive Biomarkers for an Antibody Drug Conjugate Program
Wednesday, April 15, 2026D Path a company dedicated to personalizing cancer care through a novel physicsinformed approach to predicting tumor response to therapy today announced a collaboration with Daiichi Sankyo
Avantor® Enhances U.S. Biomanufacturing Infrastructure with Expanded Stability and Microbial Testing Facility
Tuesday, April 14, 2026Avantor Inc a leading global provider of missioncritical products and services to customers in the life sciences and advanced technology industries announced the expansion of its North American
Veld Pharmaceuticals GmbH Announces Collaboration with Chiesi Farmaceutici S.p.A to Expand Access to Rare Disease Therapies Across Africa
Tuesday, April 14, 2026Veld Pharmaceuticals GmbH Veld a Switzerlandbased pharmaceutical access and services company today announced a collaboration with Chiesi Farmaceutici SpA Chiesi to expand patient access
Telix and Regeneron Announce Strategic Radiopharma Collaboration
Tuesday, April 14, 2026Telix Pharmaceuticals Limited ASX TLX NASDAQ TLX Telix and Regeneron Pharmaceuticals Inc NASDAQ REGN Regeneron today announce a collaboration to jointly develop and commercialize next generation radiopharmaceutical therapies
New CellCelector CLD takes you from thousands of candidates to the top clone, faster
Thursday, April 09, 2026Sartorius announces the launch of the CellCelector CLD an automated imaging and cell isolation platform designed to simplify and accelerate monoclonal cell line development CLD Combining highspeed scanning
